European Archives - Page 42 of 1146 - European Medical Journal

Clinical Decision-Making in OAB and BPO

An expert-led session at the European Association of Urology (EAU) Congress 2025 examined how non-invasive assessment, evidence-based…

Patient Satisfaction and Quality of Life in Long-Term Urinary Catheter Users

In recent decades, the use of urinary catheters in the Netherlands hassubstantially increased. Because of theageing population, the…

Active Surveillance in a Prostate Cancer Screening Trial in Young Men

The German PROBASE trial is an ongoing, randomised, risk-adapted prostate cancer (PCa) screening trial that primarily evaluatesthe start of…

Ureteral Stenting with Flexible Cystoscope Under Local Anaesthesia

Ureteral double J (DJ) stent placement and replacement are common urological procedures, typically performed in the operating room under…

How Well Can Women Assess Their Partner's Urinary Symptoms?

Lower urinary tract symptoms (LUTS) in men are a growing problem as more men age. For a urological evaluation of LUTS in men, the…

Reasons for Discontinuation of Active Surveillance in Men with Prostate Cancer

Active surveillance (AS) is the preferred management strategy for low-risk prostate cancer (PCa), with evidence supporting its safety for…

Accuracy of a Large Language Model in Responding to Patient-Generated Queries

The rapid advancements in AI, especially in large language models like ChatGPT (OpenAI, San Francisco, California, USA), hold potential for…

Perioperative Stone Cultures in Percutaneous Surgery

Urolithiasis may cause urinary tract infections, infections can cause urolith formation, and surgery for urolithiasis carries risk of…

Mini-Percutaneous Nephrolithotomy as an Outpatient Surgical Procedure

Percutaneous nephrolithotomy (PCNL) has traditionally been associated with a hospital stay of several days. In recent years, some…

Long-Term Outcomes of Endoscopic Therapy in High-Risk Urinary Tract Carcinoma

Upper urinary tract urothelial carcinoma (UTUC) is categorised into low-risk (LR) and high-risk (HR) groups based on patient and tumour…